G

Grace Therapeutics Inc
D

GRCE

3.05000
USD
0.15
(5.17%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
41,840,223
المقالات

العنوان: Grace Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.